NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Regulus Therapeutics Inc. (“Regulus” or the “Company”) (NASDAQ: RGLS) and certain of its officers, on behalf of a class who purchased Regulus securities between January 21, 2016 and January 27, 2016, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/rgls.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Regulus’ business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) patients treated with RG-101 were at higher risk of contracting jaundice; (2) as a result, Regulus had exaggerated RG-101’s approval prospects and/or commercial sustainability; and (3) consequently, Regulus’s public statements were materially false and misleading at all relevant times.

On June 27, 2016, Regulus released that it had received notice from the U.S. Food and Drug Administration (“FDA”) that its new drug for the treatment of chronic hepatitis C virus infection which was under FDA review, is now being put on clinical hold after a second serious case of jaundice was reported. Following this news, Regulus dropped $2.47 per share, or over 49%, to close at $2.54 on June 28, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/rgls, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Regulus, you have until April 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 454094

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Function(x) Inc. (NASDAQ: FNCX) will be presenting at this year’s MicroCap Conference on April 4th in New York City.

CONFERENCE OVERVIEW AND STRUCTURE

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

The MicroCap Conference will take place in New York City at the Essex House on April 4th. Registration will begin on Tuesday, April 4th, at 7:00AM, and will last until the evening. These days will be jam-packed with company sessions, presentations, good food, and plenty of time to network with other investors over drinks at the reception. This event does not allow service providers – only portfolio managers, analysts, and private investors.

REGISTRATION FOR INVESTORS

To register, please go to our website (www.microcapconf.com) and click “Register.”

PARTICIPATING COMPANIES

For our most updated list of companies, please go to our website (http://microcapconf.com/conferences/new-york-2017/).

MARQUEE SPONSORS

The Special Equities Group
Maxim Group

News Compliments of ACCESSWIRE.

FOR MORE INFORMATION

Please visit: www.microcapconf.com

Or, contact Tony Yu at tony@microcapconf.com.

SOURCE: Function(x) Inc.

ReleaseID: 458101

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA) and certain of its officers, on behalf of a class who purchased DaVita securities between August 5, 2015 and October 21, 2016, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/dva.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into needless insurance plans to maximize profits; (2) DaVita was using American Kidney Fund to facilitate these inappropriate practices; (3) therefore, DaVita’s revenues and profits were illegally acquired; (4) as a result, DaVita lacked effective internal controls over financial reporting; and (5) consequently, DaVita’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. Once true details were made known to the investing public, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/dva, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in DaVita, you have until April 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 454442

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against RH (formerly Restoration Hardware Holdings, Inc.) (“RH” or the “Company”) (NYSE: RH) and certain of its officers, on behalf of a class who purchased RH securities between March 26, 2015 and June 8, 2016, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/rh.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made false and misleading statements, specifically its earnings forecasts based on a new product line, RH Modern. The complaint further alleges that RH misrepresented and concealed problems surrounding the launch of RH Modern, including inventory shortages, shipping delays, and poor construction quality.

On June 8, 2016, RH revealed its financial and operating results for the first quarter of 2016 and significantly lessened its earnings guidance for fiscal year 2016, noting “accommodations largely due to…production delays” in RH’s new product line, RH Modern, which the Company had previously touted as “the most important and significant new home furnishings business to be launched in the last 15 or 20 years.” Following this news, RH stock dropped $7.66, or 21.24%, to close at $28.41 on June 9, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/rh, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in RH, you have until April 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 454515

The Fun New Desk Toy will Come in a Variety of Colors and will have a Power Output of 1V to 10V

LOS ANGELES, CA / ACCESSWIRE / March 24, 2017 / Tobi Lee is pleased to announce the upcoming launch of Tesla’s Insight, a nifty new desk toy and top that can create electricity by spinning.

To watch a video of Tesla’s Insight in action, as well as learn more about the innovative top and how it works, please check out https://goo.gl/ZlQDuX at any time.

As a spokesperson for Tesla’s Insight noted, the new top will bring to life Nikola Tesla’s vision of generating energy from a spinning magnet. People who purchase the upcoming Tesla’s Insight will have fun impressing their friends, coworkers, and family members with the brightly colored top.

The output of the red and green Tesla’s Insight is 1V to 6V AC, which is enough to power various electronics while still being safe to handle. The Tesla top will be able to spin for over 5 minutes and power LEDs for over 1 minute.

“The exact voltage will depend on the speed of the Tesla top’s spin and the orientation of the arch,” the spokesperson said, adding that the blue Tesla’s Insight has a slightly higher voltage that maxes out at around 10V.

“The blue LEDs take a higher voltage to light up and the arch contains many more loops of wire.”

The secret to Tesla’s Insight’s power is in the moving magnet, which causes electricity to flow through a nearby wire. The electricity is a product of Faraday’s law of induction, said the spokesperson.

“Nikola Tesla realized over a 100 years ago that a spinning magnet would create alternating current in nearby coils of wire – this insight is what made power plants possible all over the world.”

People who play with Tesla’s Insight will not be shocked by the top; 6V is not enough to shock human skin, the spokesperson noted.

In order to help pay for the production and marketing costs associated with bringing Tesla’s Insight to the public, Lee recently launched a fundraiser on Indiegogo. There, Lee hopes to raise $5,000 and bring the top to as many homes and offices as possible.

About Tesla’s Insight:

Nikola Tesla’s vision of creating energy from a spinning magnet is brought to life in an elegant spinning top. Tesla’s Insight is a nifty new desk toy that is being produced by Tobi Lee. For more information, please visit https://goo.gl/ZlQDuX.

Contact:

Melissa Tyler
admin@rocketfactor.com
(949) 555-2861

SOURCE: Tesla’s Insight

ReleaseID: 458098

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / HTG Molecular found it has passed the necessary technical feasibility tests for its technology to be adopted by a major scientific equipment distributor, while Flexion Therapeutics attracted a major pharmaceutical company’s attention with its OA drug. Rumors of a buyout float around investor circles.

RDI Initiates
Coverage:

HTG Molecular
Diagnostics Inc. https://ub.rdinvesting.com/news/?ticker=HTGM

Flexion Therapeutics
Inc. https://ub.rdinvesting.com/news/?ticker=FLXN

It has been a busy last few weeks for HTG Molecular Diagnostics, and it saw its stock rise spectacularly on Thursday. The company saw its stock shoot up to $3.93 a share on Thursday, up $1.79. After hours trading continued its ascent, and is definitely a stock to watch. An impressive volume of 45.45 shares were traded on Thursday, punctuating investor’s interest. The company provides instruments, reagents, and services to research companies for testing molecular profiling applications. Its HTG EdgeSeq technology has been reported as being successfully adapted to be use with the QIAGEN GeneReader NGS System. QIAGEN is into oncology business whose GeneReader system allows scientists to sequence multiple DNA samples. Earlier in the week, Investors were justifiably excited as the company’s earnings report date approached, and some added to their portfolios. HTG Molecular has reported net loss of $0.76 a share on revenue of $1.46 million reported for the fourth quarter of 2016 as compared to net loss of $0.83 a share on revenue of $1.22 million, reported in the same quarter prior year. The company had $11.8 million in cash, cash equivalents and short term investments as on December 31, 2016.

Access RDI’s HTG Molecular Research Report at: https://ub.rdinvesting.com/news/?ticker=HTGM

Flexion Therapeutics stock price rose by more than 33% on Thursday to close at $26.25 a share. The $6.57 gain was continued with additional gain in afterhours trading. Buyout rumors from Sanofi were being discussed in investor circles with offer of more than $1 billion, while there was also a speculation of a different type – that this was a false rise and the price would soon retreat. On March 9th, the company announced the plans for the launch of its plans for launching its primary product, Zilretta, in the 4th quarter of 2017. The drug treats osteoarthritis, and almost 700 patients have received the drug therapy thus far with satisfactory outcomes. In corporate news, Chief Financial Officer Frederick Driscoll is preparing to retire on March 31 of this year.

Access RDI’s Flexion Therapeutics Research Report at: https://ub.rdinvesting.com/news/?ticker=FLXN

Our Actionable Research on HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) and Flexion Therapeutics Inc. (NASDAQ: FLXN) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 458078

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Two oil and gas exploration companies still in the process of achieving a level of financial stability and growth hope to see the rest of 2017 bring profit to investors. One of the companies received an unexpected buy rating from an investment firm, while the other saw regular quarterly improvement through 2016.

RDI Initiates
Coverage:

Chesapeake Energy
Corporation https://ub.rdinvesting.com/news/?ticker=CHK

Encana Corp. https://ub.rdinvesting.com/news/?ticker=ECA

Chesapeake Energy closed the day at $5.09 a share, up by $0.09. The gain possibly came from news of a “buy” rating issued by analyst Karl Chalabala of Stifel Nicolaus, who made optimistic projections of a 10% increase in Chesapeake revenues by the end of the year, raining its stock value to double from where it sits at the end of today’s trading day. The analyst is basing the case on the promise of increased production from the company’s shale oil and gas properties, and the restructuring of its debt and asset divestitures. The company held $9.9 billion in debt on $13 billion of total assets as on February 27th of this year. Majority of other analysts are rating Chesapeake as “hold”.

In order for the analyst predictions to come true, the price of oil will have to rise and the demand for natural gas will have to increase, both events which investors in the oil and gas industry have been hoping for, but failed to materialize. Just a few weeks ago, analysts noted the very reason for Chesapeake’s price decline was those very factors, along with a shaky management structure. Some investors have waited several years for Chesapeake’s problems to shake out, and perhaps this is the time when the company may be able to take a giant step forward.

Access RDI’s Chesapeake Research Report at: https://ub.rdinvesting.com/news/?ticker=CHK

Encana stock nudged up $0.10 a share on Thursday to close at $10.65. On February 16, the company announced its 4th quarter and full year financial results. It reported that the company grew Non-GAAP Cash Flow on a quarter by quarter basis, although total yearly Non-GAAP cash flow of $838 million for the year 2016 significantly below from Non-GAAP Cash flow of $1,430 million reported in the previous year. The company finished the year 2016 with a view to continued strength in 2017. Cash from operating activities was reported to be $199 million. Also, it lowered its operation costs from drilling and completion from 30% compared to the same reporting period in 2015. Company debt was reduced by more than 50% from 2014, and full-year GAAP cash from operating activities reached $625 million.

Access RDI’s Encana Research Report at: https://ub.rdinvesting.com/news/?ticker=ECA

Our Actionable Research on Chesapeake Energy Corporation (NYSE: CHK) and Encana Corp. (NYSE: ECA) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 458077

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Alternative energy is both an environmental topic and a visionary approach to providing the world with safe energy resources. Both Plug and FuelCell are leaders in their industries, and the good news for investors continues to charge up interest in these two companies. The local and global demand for alternative energy sources continues to grow.

RDI Initiates
Coverage:

Plug Power Inc. https://ub.rdinvesting.com/news/?ticker=PLUG

FuelCell Energy Inc. https://ub.rdinvesting.com/news/?ticker=FCEL

Plug Power rose by $0.08 a share on Thursday, closing at $1.28. The company announced its 4th quarter results and its full year results for 2016 on March 9th. It reported a 4th quarter revenue of $32.6 million and a full year 2016 revenue of $85.9 million. Ending the year with $46 million in cash, the company also provided detailed sales data reflecting $16.6 million in power purchase agreements (PPAs) entered into in the 4th quarter, and an annual PPA total of $66.2 million of PPAs. Reported net loss of $19.2 million or $0.11 a share reflected improvement over net loss of $25.2 million or $0.14 a share reported in same quarter prior year, it was still short of consensus view of loss of $0.06 a share, according to Thomson Reuters. Company however reiterated 2017 GAAP revenue guidance of $130 million for the year 2017.

CEO Andy Marsh was optimistic on the result, stating that the company’s position as “the leader in hydrogen fuel cell technology within the material handling space” will continue to improve, largely suggested by a 4th quarter sales achievement of a record deployment of 1,204 GenDrive units.

Access RDI’s Plug Power Research Report at: https://ub.rdinvesting.com/news/?ticker=PLUG

FuelCell Energy saw its stock dip a bit, down by $0.025 a share to close at $1.375 on the day. The company has published a couple of news events over the past 7-10 days. On March 14th, it received $5 million credit facility from the Connecticut Green Bank to build a 3.7 Megawatt, high efficiency utility-scale project in the city of Danbury. On Monday, March 20th, the company announced the completion of a 20 megawatt fuel cell park in Seoul, South Korea, constructed by South Korean business partner POSCO Energy. Finally, on Tuesday, March 21st, the company announced in a press release that it has signed a memorandum of understanding with its partner POSCO to “directly develop the Asian fuel cell business for the purpose of expanding Asian market opportunities.” The agreement, when finalized, will allow FuelCell to commence marketing it’s suite of “SureSource” solutions for Korean and broader Asian market for the supply, recovery and storage of energy, whereas POSCO energy will continue to service existing installed base of FuelCell plants in South Korea and will commit to specific level of module purchases from FuelCell Energy to supplement its own manufacturing for servicing their existing fleet.

Access RDI’s FuelCell Research Report at: https://ub.rdinvesting.com/news/?ticker=FCEL

Our Actionable Research on Plug Power Inc. (NASDAQ: PLUG) and FuelCell Energy Inc. (NASDAQ: FCEL) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 458075

NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Shares of McDonald’s Corp. and Starbucks both were slightly lower as the trading day ended Thursday. As the companies made changes to their top management structure, other issues were clouding stock values, in part from both companies seeking to advance their technology to be more consumer-friendly.

RDI Initiates
Coverage:

Starbucks Corporation https://ub.rdinvesting.com/news/?ticker=SBUX

McDonald’s
Corporation https://ub.rdinvesting.com/news/?ticker=MCD

Starbucks’ stock dropped by $0.04 a share to close at $55.85. The company has found itself in the middle of conservative consumer revolt after its announcement that it would hire 10,000 refugees worldwide in a protest to President Trump’s immigration actions. Some advertising and marketing agencies are saying that such actions have hurt the company brand, particularly in light of the fact that four years ago Starbucks had promised to hire 10,000 veterans and military family spouses.

Beyond the political controversies, the company today announced stockholders have elected three new members to the board of directors. Satya Nadella, Rosalind Brewer, and Jørgen Vig Knudstorp. These additions are moving in as now former CEO Howard Schultz is leaving. As a director, Nadella won’t have any specific role in company’s day to day operations, but he might be helpful to offer some insight to Starbucks’ new CEO Kevin Johnson to fix some concerns like long customer waiting time for walk-in customers. Starbucks introduced a mobile application 18 months ago that allowed customers to order ahead, and quickly has been popular, but individual stores have had trouble keeping up with the crunch-time traffic, leaving walk-in customers unhappily waiting.

Access RDI’s Starbucks Research Report at: https://ub.rdinvesting.com/news/?ticker=SBUX

McDonald’s closed the trading day at $129.00 per share, down $0.10. McDonald’s is into the burger and fast-food business, similar to Starbucks that is in the specialty coffee business and, as Starbucks has started offering some technological solutions, McDonald’s also started hiring people in this direction. Bob Rupczynski, an experienced marketer whose approach is heavily data-driven, has been hired as the company’s global vice president of media and customer relationship management. McDonald’s has seen its sales lagging recently, and is implementing a plan to make its digital marketing plan more robust and effective. Mobile ordering is on the company’s menu for 20,000 stores across the United States. It can be safely said that McDonald’s took notice of Starbucks own mobile app troubles and brought Rupczynski in to head off any potential customer complaints.

Earlier this week, the company announced it would be making the Big Mac, Filet-O-Fish and McChicken sauces available in Canadian grocery stores across the country for off-the-shelf sale. While no details were immediately available, the company is clearly focusing on improving customer relations globally in hopes of rekindling customer interest in the brand.

Access RDI’s McDonald’s Research Report at: https://ub.rdinvesting.com/news/?ticker=MCD

Our Actionable Research on Starbucks Corporation (NASDAQ: SBUX) McDonald’s Corporation (NYSE: MCD) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 458074